A dermatology wRVU benchmark only means something once you know what “dermatology” refers to in that number. A general dermatologist doing high-volume medical dermatology, a Mohs surgeon, and a cosmetic-heavy practitioner can post wildly different annual work RVU totals while all being “dermatology.” Before comparing a proposed target against any published percentile, the practice model behind the number has to be identified first.
Work RVU Is Not the Same as Medicare Payment
This distinction matters more in dermatology than in almost any other specialty, because dermatology contracts frequently mix wRVU-based pay with cosmetic revenue splits, collections, or hybrid formulas.
Work RVU (wRVU) measures the physician labor, time, skill, and intensity assigned to a CPT or HCPCS code under the Medicare Physician Fee Schedule (MPFS). It is one input used by many employers to calculate physician compensation — but it is not itself a payment amount.
Medicare payment, by contrast, is derived from the total RVU for a code (work RVU + practice expense RVU + malpractice RVU), adjusted by locality-specific Geographic Practice Cost Indices (GPCIs), then multiplied by the annual Conversion Factor (CF) that CMS publishes with each year’s MPFS update.
| Concept | What it measures | Who sets/uses it |
|---|---|---|
| Work RVU | Physician time, skill, effort for a specific CPT/HCPCS code | CMS (basis); often adopted by employers for compensation |
| Practice Expense (PE) RVU | Overhead: staff, supplies, equipment, space | CMS |
| Malpractice (MP) RVU | Liability insurance cost component | CMS |
| Total RVU | Work + PE + MP RVU | CMS |
| GPCI | Local cost-of-practice adjustment applied to each RVU component | CMS, updated periodically by locality |
| Conversion Factor | Dollar multiplier applied to the GPCI-adjusted total RVU | CMS, set annually |
| wRVU-based compensation | Employer-defined pay formula using work RVU as the production metric | Individual practice/health system contract |
A dermatologist can generate a large number of wRVUs from an efficient biopsy-and-destruction clinic day without that number telling you anything about the group’s actual Medicare collections, because collections also depend on payer mix, PE/MP RVU, GPCI locality, and the CF in effect that year. Use RVUinUSA’s RVU Calculator to separate a code’s work RVU component from its total RVU before drawing conclusions about pay versus payment.
Practice Model Drives the Benchmark
Dermatology wRVU output is not one number — it is a range that shifts with the clinical model:
- Medical dermatology: driven by E/M visit volume, skin biopsies, cryotherapy, and other minor in-office procedures. Throughput depends on room turnover and support staff more than on any single high-value code.
- Procedural/surgical dermatology (including Mohs): production is concentrated in fewer, higher-wRVU encounters per patient, with different scheduling and staffing needs than a high-volume medical clinic.
- Cosmetic dermatology: many cosmetic services (e.g., cosmetic injectables, laser resurfacing done for aesthetic rather than medically necessary reasons) are self-pay and are not billed to Medicare at all, so they may be excluded from wRVU credit entirely or compensated under a separate cash/revenue-share formula.
- Academic dermatology: clinical wRVU is often blended with teaching, research, and administrative time, which lowers the clinical wRVU expectation relative to a pure private-practice role.
- Mixed/community practice: a combination of the above, where the target should reflect the actual scheduled ratio of E/M to procedure volume, not an average pulled from a different model.
Before evaluating a target against a benchmark survey (such as those from MGMA or AMGA), confirm that the survey’s dermatology subspecialty categorization matches the role being offered. A “dermatology” median that pools Mohs surgeons with general dermatologists will overstate what a medical-dermatology-only role should produce, and understate what a Mohs-heavy role should produce.
CPT Drivers Behind the Number
Instead of judging an annual wRVU figure in isolation, it helps to look at what services typically generate it. Common dermatology-adjacent CPT categories include:
- Office/outpatient E/M visits (new and established patient levels)
- Skin biopsy procedures
- Destruction of benign or premalignant lesions
- Excision of benign and malignant lesions
- Wound repair (simple, intermediate, complex) following excision
- Intralesional injections
- Mohs micrographic surgery stages
Each of these codes carries its own CMS-assigned work RVU, and that value can change from year to year during the annual MPFS rulemaking cycle, so any specific wRVU figure attached to a code should be checked against the current-year MPFS rather than assumed to be fixed. RVUinUSA’s CPT RVU reference pages list code-level work RVU, PE RVU, and MP RVU by year — use those pages to check the current value for a specific code rather than relying on a benchmark article’s cited figure, which may reflect an older MPFS release.
A benchmark built on high procedural throughput assumes a clinic infrastructure to match: adequate rooming capacity, procedure-trained staff, efficient scheduling templates, and enough patient demand to fill the schedule. A wRVU target copied from a high-volume, well-supported clinic is not automatically achievable in a practice with fewer exam rooms or less experienced support staff.
Cosmetic Exclusions and Threshold Design
Because cosmetic dermatology revenue typically falls outside Medicare and most commercial insurance billing, employment contracts have to state explicitly how it interacts with the wRVU threshold:
- Does cosmetic work count toward the wRVU threshold at all, or is it excluded because it generates no CPT-billed wRVU?
- If cosmetic services are compensated separately (e.g., a percentage of cosmetic collections), is that stacked on top of the wRVU-based clinical compensation, or does it replace it for those encounters?
- How are self-pay procedures, supervision of advanced practice providers, pathology interpretation, and other ancillary services treated — counted toward the threshold, paid separately, or excluded?
None of these questions have a universal answer; they are set by the individual employment agreement. A dollars-per-wRVU rate quoted in a contract typically applies only to the wRVU-generating clinical work defined in that contract — not to cosmetic or ancillary revenue streams handled under a different formula. Use RVUinUSA’s contract analyzer to document each of these exclusions as a discrete line item before comparing the offered rate to a market benchmark.
Ramp-Up: Why a High Target Isn’t Automatically Realistic
A wRVU target that is achievable in a mature, high-demand dermatology clinic with a full referral base can be unrealistic for a new physician still building a panel. Two contracts quoting the same annual wRVU threshold are not equivalent if one includes ramp-up protection and the other does not.
Items worth reviewing against the benchmark:
- Is the threshold prorated on a monthly or quarterly basis during a defined ramp-up period (commonly the first 12–24 months)?
- What new-patient volume and referral pipeline does the employer commit to (marketing support, existing patient panel transfer, referral network access)?
- Is there a base salary guarantee independent of wRVU production during ramp-up, and for how long?
- What does a downside production scenario look like if referral volume builds slower than projected?
Modeling first-year, mature-year, and downside scenarios side by side — rather than relying on a single steady-state annual figure — gives a more honest picture of whether the benchmark target is attainable in the specific practice setting being offered.
Turning a wRVU Target into an Estimated Medicare Payment (Illustrative Only)
To see how wRVU connects to an estimated Medicare payment for a single service — as distinct from the physician’s compensation — the general MPFS payment logic is:
Estimated Medicare payment ≈ [(Work RVU × Work GPCI) + (PE RVU × PE GPCI) + (MP RVU × MP GPCI)] × Conversion Factor
Using illustrative, non-official example values to show the mechanics (these are not actual MPFS figures for any real code or year):
| Component | Example RVU | Example GPCI | GPCI-adjusted value |
|---|---|---|---|
| Work RVU | 1.00 | 1.00 | 1.00 |
| PE RVU | 1.20 | 0.95 | 1.14 |
| MP RVU | 0.10 | 1.00 | 0.10 |
| Total (adjusted) | 2.24 |
Estimated payment = 2.24 × example Conversion Factor of $33.00 = $73.92 (illustrative figure only, not an actual CMS rate)
This example demonstrates the mechanism, not a real payment amount for any dermatology CPT code. The actual work RVU, PE RVU, MP RVU, GPCI values by locality, and the Conversion Factor all change with each year’s MPFS update, and PE RVU can also vary by site of service (facility vs. non-facility). For an actual code and year, look up the current values through RVUinUSA’s Medicare reimbursement calculator or GPCI calculator rather than reusing figures from a prior year’s article.
Separately, and just as important: this Medicare-payment math has nothing to do with how much a physician is paid per wRVU under an employment contract. A dermatologist’s compensation rate (dollars per wRVU) is negotiated between physician and employer and is independent of what Medicare actually reimburses for the underlying service.
Putting the Benchmark to Use
A practical review sequence looks like this:
- Confirm the practice model (medical, procedural/Mohs, cosmetic-heavy, academic, or mixed) before comparing against any published benchmark.
- Pull the CPT codes expected to drive volume and check their current work RVU, PE RVU, and MP RVU using a code-level RVU reference tool.
- Use a salary/compensation estimator to model the offered dollars-per-wRVU rate against realistic first-year and mature-year production.
- Document cosmetic exclusions, ancillary treatment, ramp-up proration, and guarantee terms as explicit contract items rather than assumptions.
- Keep the Medicare payment estimate for the underlying codes separate from the wRVU-based compensation calculation — they answer different questions.
A dermatology wRVU number is only a useful benchmark once it’s tied to the specific clinical model, the CPT mix behind it, the contract’s treatment of cosmetic and ancillary work, and realistic ramp-up assumptions — not when it’s compared as a single annual figure against an industry-wide median.